22 May 2013 | News | By BioSpectrum Bureau
Stemage is an unique natural skin rejuvenation system that targets visible signs of aging through the use of human mesenchymal stem cell derivatives
Singapore: Ms Kathy Ireland, CEO and chief designer of kathy ireland Worldwide (kiWW) and Dr David Scharp, leading women's health advocate and world-renowned board certified surgeon, have collaborated to bring a stem cell-derived product brand named Stemage, to the beauty market.
Stemage is an unique natural skin rejuvenation system that targets visible signs of aging through the use of human mesenchymal stem cell derivatives, which are not stem cells but are rather active ingredients or derivatives of which stem cells are comprised.
The three-step skin rejuvenation system's core active ingredient is a proprietary stem cell derivative called MDFc19, or mesenchymal derived factor complex 19. All of the ingredients found in Stemage are either naturally sourced from botanicals and minerals or naturally produced biologically. Stemage addresses skincare challenges associated with aging using these stem cell derivatives and other proven natural ingredients, leaving skin soft, smooth and luminous.
Ms Kathy Ireland said that, "Skin care is one of my passions. My work and my life were impacted by troubled skin. Stemage is new, powerful and extraordinary. Expect to feel and see something different. Our relationship with the researchers and executive team at Stemage is responsible for a strategic alliance, between our two companies."